Our projects

VNGBC IN TALK WITH MD COLLEGE OF AUSTRALIA

VNGBC recently had a meeting with a potential Australian partner to discuss the possibility of obtaining Australian certificates for students while providing training in Vietnam through MD College of Australia. This partnership would offer Vietnamese students the opportunity to receive high-quality education and training in their own country, while still obtaining internationally recognized qualifications. The collaboration between VNGBC and the Australian partner aims to enhance educational opportunities for Vietnamese students and bridge the gap between international standards and local education. By bringing the expertise and curriculum of MD College of Australia to Vietnam, students will have access to a comprehensive and industry-relevant education that will prepare them for successful careers in their chosen fields. This partnership represents a significant step towards advancing educational opportunities and fostering global connections for students in Vietnam.

ISO/IEC 17024

ISO/IEC 17024 is an international standard that sets the requirements for the certification of personnel. It provides a framework for organizations to develop certification programs and ensures that these programs are fair, valid, and reliable. The standard outlines the criteria for the competence of certifying bodies and the processes they must follow to assess and certify individuals. ISO/IEC 17024 emphasizes the importance of impartiality, confidentiality, and competence in the certification process. It also requires certifying bodies to have a systematic approach to managing their operations and maintaining the quality of their certification programs. Adhering to ISO/IEC 17024 helps organizations enhance their credibility and ensures that certified individuals have the necessary skills and knowledge to perform their job roles effectively.

mRNA TECHNOLOGY CURING SKIN MELASMA

Using mRNA technology to cure skin melasma is a revolutionary approach in the field of dermatology. Melasma is a common skin condition that causes dark patches on the face, and traditional treatment options have often fallen short in delivering long-term results. However, with the advent of mRNA technology, there is renewed hope for those suffering from melasma. This innovative approach involves introducing specific mRNA molecules into the skin cells, which helps to regulate the production of melanin, the pigment responsible for skin color. By targeting the underlying cause of melasma at a molecular level, mRNA technology holds promise for providing more effective and lasting solutions for those affected by this condition. Ongoing research and clinical trials are underway to further explore the potential of using mRNA technology as a game-changing treatment for skin melasma.